Trials / Completed
CompletedNCT02106403
A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The objective of this randomised, examiner and subject blinded study is to evaluate and compare cooling performance and overall consumer liking of the prototype formulation with the currently marketed wound spray and negative control in subjects with experimental wounds. For each subject, three superficial wounds will be induced on two volar forearms, by sequential tape strippings until a glistening layer is visualized. After wounding, a randomised test product will be sprayed twice on test site, and the subject will be asked to complete a questionnaire evaluating product cooling performance and overall liking.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prototype disinfectant spray formulation | 0.13% w/w BAC and 1% MGA. After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound |
| OTHER | Reference product | 0.13% w/w BAC. After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound |
| OTHER | Negative control | 0.9% w/v sodium chloride solution. After wounding, the product will be held approximately 10 cm above the wounding area, and sprayed twice towards the wound |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2014-04-08
- Last updated
- 2015-02-11
- Results posted
- 2015-02-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02106403. Inclusion in this directory is not an endorsement.